APA (7th ed.) Citation

Kolwelter, J., Bosch, A., Jung, S., Stabel, L., Kannenkeril, D., Ott, C., . . . Schmieder, R. E. (2022). Effects of the sodium-glucose cotransporter 2 inhibitor empagliflozin on vascular function in patients with chronic heart failure. Friedrich-Alexander-Universität Erlangen-Nürnberg.

Chicago Style (17th ed.) Citation

Kolwelter, Julie, et al. Effects of the Sodium-glucose Cotransporter 2 Inhibitor Empagliflozin on Vascular Function in Patients with Chronic Heart Failure. Erlangen ; Nürnberg: Friedrich-Alexander-Universität Erlangen-Nürnberg, 2022.

MLA (9th ed.) Citation

Kolwelter, Julie, et al. Effects of the Sodium-glucose Cotransporter 2 Inhibitor Empagliflozin on Vascular Function in Patients with Chronic Heart Failure. Friedrich-Alexander-Universität Erlangen-Nürnberg, 2022.